Info
13F
Schedule 13D
Ownership

Orbimed Advisors Llc - Significant Ownership

Signature - Title: /s/ Carl L. Gordon - Carl L. Gordon/Member
Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Orbimed Advisors Llc.

Significant Ownership of Orbimed Advisors Llc

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
TRAW	Traws Pharma, Inc.	Common Stock	19.9%	$1.16M		761K		ORBIMED ADVISORS LLC	Dec 31, 2024
EWTX	Edgewise Therapeutics, Inc.	Common Stock	14.5%	$235M		15.3M		ORBIMED ADVISORS LLC	May 9, 2025
CRVS	CORVUS PHARMACEUTICALS, INC.	Common stock, par value $0.0001 per share (the "Shares").	12.2%	$35.4M		9.79M	0%	ORBIMED ADVISORS LLC	May 12, 2025
CMPX	Compass Therapeutics, Inc.	COMMON STOCK	11%	$29.5M		15.2M		ORBIMED ADVISORS LLC	Apr 9, 2024
PASG	Passage BIO, Inc.	Common Stock	10.7%	$2.19M	-$249K	6.65M	-10.2%	ORBIMED ADVISORS LLC	Apr 22, 2025
NPCE	NeuroPace Inc	Common Stock, par value $0.001 per share	10.5%	$39.6M		3.41M		OrbiMed Advisors LLC	Mar 31, 2025
RAPT	RAPT Therapeutics, Inc.	Common Stock, par value $0.0001 per share	9.9%	$11.4M		13.1M		ORBIMED ADVISORS LLC	Dec 31, 2024
WHWK	Whitehawk Therapeutics, Inc.	Common Stock, par value $0.0001 per share	8.9%	$6.42M		4.17M		OrbiMed Advisors LLC	Mar 31, 2025
SION	Sionna Therapeutics, Inc.	Common Stock	8.4%	$44.6M		3.7M		ORBIMED ADVISORS LLC	Feb 10, 2025
FBRX	Forte Biosciences, Inc.	Common Stock, par value $0.001 per share	8%	$3.76M		510K		ORBIMED ADVISORS LLC	Dec 31, 2024
NSPR	InspireMD, Inc.	Common Stock, par value $0.0001 per share	7.2%	$5.25M		2.13M		OrbiMed Advisors LLC	Mar 31, 2025
CCCC	C4 Therapeutics, Inc.	Common Stock, par value $0.0001 per share	6.6%	$7.17M		4.66M		OrbiMed Capital LLC	Mar 31, 2025
CRBP	Corbus Pharmaceuticals Holdings, Inc.	Common Stock, par value $0.0001 per share	5.9%	$5.31M		718K		OrbiMed Capital LLC	Dec 31, 2024
VSTM	Verastem, Inc.	Common Stock, par value $0.0001 per share	5.6%	$20M		2.86M		OrbiMed Advisors LLC	Mar 31, 2025
IRON	Disc Medicine, Inc.	Common Stock	4.5%	$73.4M		1.56M		ORBIMED ADVISORS LLC	Mar 10, 2025
ADCT	ADC Therapeutics SA	Common Shares, par value CHF 0.08 per share	3.6%	$5.02M		3.44M		ORBIMED CAPITAL LLC	Dec 31, 2024
XTNT	Xtant Medical Holdings, Inc.	COMMON STOCK	0%	$0		0		ORBIMED ADVISORS LLC	Apr 10, 2025

Showing 1 to 17 of 17 entries

Schedules 13D/G Reported by Orbimed Advisors Llc:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.